Loading…

Racial Differences in Blood Pressure Response to Angiotensin-Converting Enzyme Inhibitors in Children: A Meta-Analysis

Angiotensin‐converting enzyme (ACE) inhibitors are frequently used to treat hypertension in children.1 ACE inhibitors alter the balance between the vasoconstrictive, salt‐retentive, and cardiac hypertrophic properties of angiotensin II and the vasodilatory and natriuretic properties of bradykinin; t...

Full description

Saved in:
Bibliographic Details
Published in:Clinical pharmacology and therapeutics 2008-09, Vol.84 (3), p.315-319
Main Authors: Li, JS, Baker‐Smith, CM, Smith, PB, Hasselblad, V, Murphy, MD, Califf, RM, Benjamin, DK
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Angiotensin‐converting enzyme (ACE) inhibitors are frequently used to treat hypertension in children.1 ACE inhibitors alter the balance between the vasoconstrictive, salt‐retentive, and cardiac hypertrophic properties of angiotensin II and the vasodilatory and natriuretic properties of bradykinin; they also alter the metabolism of other vasoactive substances.2 Through these mechanisms, ACE inhibitors decrease systemic vascular resistance and promote natriuresis without increasing heart rate. This study evaluated the results of six trials of ACE inhibitors in children, using meta‐analytic techniques to estimate the effect of race on blood pressure response. Clinical Pharmacology & Therapeutics (2008); 84, 3, 315–319 doi:10.1038/clpt.2008.113
ISSN:0009-9236
1532-6535
DOI:10.1038/clpt.2008.113